REGULATION OF IMMUNE RESPONSES BY TGF-β*
暂无分享,去创建一个
[1] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[2] D. Riches,et al. Autocrine/paracrine involvement of platelet-activating factor and transforming growth factor-beta in the induction of phosphatidylserine recognition by murine macrophages. , 1995, Journal of Immunology.
[3] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[4] F. Paliogianni,et al. Effect of transforming growth factor-beta on early and late activation events in human T cells. , 1993, Journal of immunology.
[5] Gary R. Grotendorst,et al. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils , 1989, Journal of cellular physiology.
[6] M. Pearse,et al. Development of immature thymocytes: initiation of CD3, CD4, and CD8 acquisition parallels down‐regulation of the interleukin 2 receptor α chain , 1990, European journal of immunology.
[7] Å. Schiött,et al. Monocyte‐Dependent Costimulatory Effect of TGF‐β1 on Rat T‐Cell Activation , 1996, Scandinavian journal of immunology.
[8] H. Gresham,et al. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice , 1994, The Journal of experimental medicine.
[9] A. Sher,et al. The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β , 1992, European journal of immunology.
[10] H. Lodish,et al. Loss of functional cell surface transforming growth factor β (TGF-β) type 1 receptor correlates with insensitivity to TGF-β in chronic lymphocytic leukemia , 1997 .
[11] H. Weiner,et al. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. , 1995, Journal of immunology.
[12] S. Reed,et al. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. , 1992, Science.
[13] L. Bermudez,et al. Production of TNF-alpha, IL-6 and TGF-beta, and expression of receptors for TNF-alpha and IL-6, during murine Mycobacterium avium infection. , 1995, Immunology.
[14] J. W. Rooney,et al. Transforming growth factor β1 repression of the HLA-DRα gene is mediated by conserved proximal promoter elements , 1993 .
[15] D. Rifkin,et al. Activation of Latent Transforming Growth Factor ß , 1993 .
[16] M. Sporn,et al. Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[17] T. Nutman,et al. Differential effect of transforming growth factor β on the synthesis of Th1‐ and Th2‐like lymphokines by human T lymphocytes , 1992, European journal of immunology.
[18] S. Wahl,et al. Transforming growth factor beta: the good, the bad, and the ugly , 1994, The Journal of experimental medicine.
[19] S. Reed,et al. Transforming growth factor-beta in human cutaneous leishmaniasis. , 1995, The American journal of pathology.
[20] M. Feldmann,et al. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor‐β , 1991, European journal of immunology.
[21] J. Liesveld,et al. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors. , 1997, Journal of immunology.
[22] A. Geiser,et al. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. , 1995, Journal of immunology.
[23] H. Fujiwara,et al. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. , 1991, Journal of immunology.
[24] D. Scott,et al. Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[25] R. Macdermott. Alterations of the mucosal immune system in inflammatory bowel disease. , 1996, Journal of gastroenterology.
[26] B. Chen,et al. Transforming growth factor-beta 1 bifunctionally regulates murine macrophage proliferation. , 1992, Blood.
[27] H. Gresham,et al. Defective neutrophil function in the autoimmune mouse strain MRL/lpr. Potential role of transforming growth factor-beta. , 1991, Journal of immunology.
[28] H. Weiner,et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. , 1994, Science.
[29] H. Weiner,et al. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. , 1996, The Journal of clinical investigation.
[30] A. Weinberg,et al. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. , 1991, Journal of immunology.
[31] A. Roberts,et al. TGF-β: A Critical Modulator of Immune Cell Function☆ , 1997 .
[32] I. Bernard,et al. Transforming Growth Factor β (TGF-β)-dependent Inhibition of T Helper Cell 2 (Th2)-induced Autoimmunity by Self–Major Histocompatibility Complex (MHC) Class II–specific, Regulatory CD4+ T Cell Lines , 1997, The Journal of experimental medicine.
[33] S. Reed,et al. Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[34] Y. Vodovotz,et al. Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. , 1994, Progress in growth factor research.
[35] A. Kulkarni,et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. , 1996, The Journal of clinical investigation.
[36] B. Ludviksson,et al. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation , 1997 .
[37] D. Roop,et al. A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice. , 1997, The Journal of clinical investigation.
[38] J. Massagué,et al. Loss of receptors for transforming growth factor beta in human T-cell malignancies. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Sporn,et al. Maternal rescue of transforming growth factor-beta 1 null mice. , 1994, Science.
[40] H. Gresham,et al. Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection. , 1996, The Journal of clinical investigation.
[41] D. Berg,et al. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes. , 1991, Journal of immunology.
[42] R. Maki,et al. Transforming growth factor-beta enhances the M-CSF and GM-CSF-stimulated proliferation of macrophages. , 1992, Journal of immunology.
[43] W. Paul,et al. Lymphocyte responses and cytokines , 1994, Cell.
[44] G. Wong,et al. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. , 1988, Journal of immunology.
[45] M. Barral-Netto,et al. Transforming growth factor-beta in tegumentary leishmaniasis. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[46] M. Palladino,et al. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Coffman,et al. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells , 1996, The Journal of experimental medicine.
[48] M. Sporn,et al. TGF-beta: problems and prospects. , 1990, Cell regulation.
[49] S. Gollnick,et al. Effects of transforming growth factor-beta on bone marrow macrophage Ia expression induced by cytokines. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[50] P. Debré,et al. Early human thymocyte proliferation is regulated by an externally controlled autocrine transforming growth factor-beta 1 mechanism. , 1995, Blood.
[51] R. Silverstein,et al. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[52] T. Mosmann,et al. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. , 1994, Journal of immunology.
[53] D. Rowley,et al. A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens , 1993, The Journal of experimental medicine.
[54] O. Majdic,et al. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. , 1996, Journal of immunology.
[55] M. Sporn,et al. Comparison of transforming growth factor-beta and a macrophage- deactivating polypeptide from tumor cells. Differences in antigenicity and mechanism of action. , 1989, Journal of immunology.
[56] S. Swain,et al. Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion , 1995, The Journal of experimental medicine.
[57] O. Majdic,et al. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. , 1996, Journal of immunology.
[58] Edgar Schmitt,et al. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin‐12 and interferon‐γ and is inhibited by transforming growth factor‐β , 1994 .
[59] M. Sporn,et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth , 1986, The Journal of experimental medicine.
[60] A. Kulkarni,et al. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Ewen,et al. Trypanosome invasion of mammalian cells requires activation of the TGFβ signaling pathway , 1995, Cell.
[62] E. Tartour,et al. A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor , 1995, The Journal of experimental medicine.
[63] J. Letterio,et al. A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor β1 Null Mice Is Devoid of Epidermal Langerhans Cells , 1996, The Journal of experimental medicine.
[64] M. Yamakawa,et al. Morphology, function and pathology of follicular dendritic cells , 1996, Pathology international.
[65] D. Kamp,et al. Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity. , 1988, Biochemical and biophysical research communications.
[66] M. Murtaugh,et al. Cocaine-mediated suppression of superoxide production by human peripheral blood mononuclear cells. , 1991, The Journal of pharmacology and experimental therapeutics.
[67] E. Smeland,et al. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. , 1995, Journal of immunology.
[68] S. Wahl,et al. Transforming growth factor β: a matter of life and death , 1994 .
[69] W. Border,et al. Transforming Growth Factor β in Tissue Fibrosis , 1994 .
[70] O. Majdic,et al. TGF-beta 1 is a potent inducer of human effector T cells. , 1994, Journal of immunology.
[71] A. Singer,et al. Early progression of thymocytes along the CD4/CD8 developmental pathway is regulated by a subset of thymic epithelial cells expressing transforming growth factor beta , 1994, The Journal of experimental medicine.
[72] H. Shepard,et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor beta , 1987, The Journal of experimental medicine.
[73] F. Ruscetti,et al. Transforming growth factor- and the immune system , 1991 .
[74] H. Bear,et al. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes. , 1992, Journal of immunology.
[75] D. Rouillard,et al. IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. , 1992, Journal of immunology.
[76] M. Sporn,et al. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. , 1986, Journal of immunology.
[77] A. Zlotnik,et al. In vitro induction of CD8 expression on thymic pre-T cells. II. Characterization of CD3-CD4-CD8 alpha + cells generated in vitro by culturing CD25+CD3-CD4-CD8- thymocytes with T cell growth factor-beta and tumor necrosis factor-alpha. , 1992, Journal of immunology.
[78] G. Proetzel,et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.
[79] D. Rouillard,et al. TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma: dependence on alpha 5 beta 1 and beta 2 integrins. , 1996, Experimental cell research.
[80] C. Snapper,et al. Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. , 1993, Journal of immunology.
[81] H. Krutzsch,et al. Regulation of Transforming Growth Factor-β Activation by Discrete Sequences of Thrombospondin 1 (*) , 1995, The Journal of Biological Chemistry.
[82] A. Steinberg. MRL-lpr/lpr disease: theories meet Fas. , 1994, Seminars in immunology.
[83] D. Rifkin,et al. Characterization of latent TGF-beta activation by murine peritoneal macrophages. , 1995, Journal of immunology.
[84] D. Rowley,et al. Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses , 1995, The Journal of experimental medicine.
[85] T. McCaffrey,et al. THP‐1 macrophage membrane‐bound plasmin activity is up‐regulated by transforming growth factor‐β1 via increased expression of urokinase and the urokinase receptor , 1995 .
[86] M. Sporn,et al. Transforming growth factor beta. , 1988, Advances in cancer research.
[87] M. Sporn,et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[88] R. Seder,et al. Regulation of transforming growth factor‐β production by interleukin‐12 , 1997 .
[89] S. Wahl,et al. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. , 1990, Growth factors.
[90] C. Nathan,et al. Modulation of Macrophage Function by Transforming Growth Factor β, Interleukin‐4, and Interleukin‐10 a , 1993, Annals of the New York Academy of Sciences.
[91] M. Biffi,et al. Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells , 1997, Journal of Experimental Medicine.
[92] R. Coffman,et al. Multiple Pathways for the Initiation of T Helper 2 (Th2) Responses , 1997, The Journal of experimental medicine.
[93] J. Letterio,et al. TGF-β Knockout and Dominant-Negative Receptor Transgenic Mice , 1998, Mineral and Electrolyte Metabolism.
[94] M. Sporn,et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[95] M. Feldmann,et al. Interleukin 7 (murine pre‐B cell growth factor/lymphopoietin 1) stimulates thymocyte growth: regulation by transforming growth factor beta , 1989, European journal of immunology.
[96] O. Majdic,et al. TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. , 1997, Journal of immunology.
[97] J. Wrana,et al. Signal transduction by members of the transforming growth factor-β superfamily , 1996 .
[98] M. Holder,et al. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor‐β, but not cyclosporin A or anti‐CD19, block surface immunoglobulin‐mediated rescue from apoptosis , 1992, European journal of immunology.
[99] M. Sporn,et al. Autocrine Secretion—10 Years Later , 1992, Annals of Internal Medicine.
[100] J. Nikolić-Žugić. Phenotypic and functional stages in the intrathymic development of αβ T cells , 1991 .
[101] A. Waage,et al. Regulation of interleukin-2 and interleukin-6 production from T-cells: Involvement of interleukin-1 β and transforming growth factor-β , 1990 .
[102] A. Kulkarni,et al. Immune dysregulation in TGF-beta 1-deficient mice. , 1994, Journal of immunology.
[103] S. Wahl,et al. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[104] T. Matsumura,et al. Lipoprotein(a) induces cell growth in rat peritoneal macrophages through inhibition of transforming growth factor-beta activation. , 1996, Atherosclerosis.
[105] B. Vandekerckhove,et al. Influence of TGF-beta on murine thymocyte development in fetal thymus organ culture. , 1995, Journal of immunology.
[106] S. Reed,et al. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta) , 1991, The Journal of experimental medicine.
[107] A. Zlotnik,et al. IL-7 maintains the T cell precursor potential of CD3-CD4-CD8- thymocytes. , 1991, Journal of immunology.
[108] W. Strober,et al. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. , 1996, Journal of immunology.
[109] M. Sporn,et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[110] M. Sporn,et al. Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. , 1992, International immunology.
[111] G. Pawelec,et al. Cytokine modulation of TH1/TH2 phenotype differentiation in directly alloresponsive CD4+ human T cells. , 1996, Transplantation.
[112] V. Kindler,et al. Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs , 1993, The Journal of experimental medicine.
[113] N. Khalil,et al. Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. , 1996, American journal of respiratory cell and molecular biology.
[114] S. Wahl,et al. Selective induction of Fc gamma RIII on human monocytes by transforming growth factor-beta. , 1990, Journal of immunology.
[115] H. D. Liggitt,et al. Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[116] G. Herrera,et al. Pathogenesis of glomerulosclerosis in light chain deposition disease. Role for transforming growth factor-beta. , 1995, The American journal of pathology.
[117] F. Mami-Chouaib,et al. Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response. , 1997, Journal of immunology.
[118] W. Paul,et al. Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, Annual review of immunology.
[119] H. Young,et al. Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. , 1991, Journal of immunology.
[120] T. Kipps,et al. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells , 1994, The Journal of experimental medicine.
[121] E. Fikrig,et al. Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T Cells , 1997, The Journal of experimental medicine.
[122] H. M. Lee,et al. Role of alpha 5 beta 1 integrin in TGF-beta 1-costimulated CD8+ T cell growth and apoptosis. , 1996, Journal of immunology.